Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder
Clinical trial NCT06319170 · COMPLETED
Trial details
- NCT number
- NCT06319170
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2025-01-15
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.